RHAPSODY
Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
Site Search
Site Search
Displaying results 641 - 650 of 893
VAC2VAC
Vaccine lot to vaccine lot comparison by consistency testing
62nd Edition – November 2016
Table of contents:
- Interested in our new Call 10 topics? Read our tips for applicants
- PROactive draws to a close, delivers on its promises – an interview with project coordinators
- ADAPTED project to boost development of new medicines for Alzheimer’s
- European Lead Factory featured on Euronews
- IMI at the Pharmaceutical Science World Congress (PSWC) 2017
- Alzheimer's disease: advancing research through collaboration
- ‘Play Decide’ game workshop brought to the European Parliament by eTRIKS
- Congratulations to the recently appointed members of IMI’s Scientific Committee
- News from the projects
PROactive draws to a close, delivers on its promises – an interview with project coordinators
PROactive was launched in 2009 with the aim of developing an innovative tool to measure physical activity in chronic obstructive pulmonary disease (COPD) patients. The project has now drawn to a close, meeting its main goal. In interview with the IMI Programme Office, PROactive’s ...
Open Innovation case studies
Putting open innovation into practice – case studies from Europe An IMI symposium at the 6th Pharmaceutical Science World Congress (PSWC) IMI is working to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an ...
61st Edition – October 2016
Table of contents:
- ‘It’s been a great first year’ – an interview with Pierre Meulien
- Got an idea for an IMI project? We want to hear from you
- Missed the Stakeholder Forum? Catch up online!
- IMI at the European Week of Regions and Cities
- Join IMI in the European Parliament to talk dementia
- IMI 2 – Call 10 – coming soon
- AMYPAD project to focus on brain scans in Alzheimer’s disease
- New PREFER project to give patients a voice in drug development
- News from the projects
Alzheimer's disease collaboration
IMI roundtable discussion at the European Parliament - Alzheimer's disease: advancing research through collaboration About one in twenty people over the age of 65 develops Alzheimer's disease. The disease kills more than breast and a prostatic cancer combined, and there is an ...
"It’s been a great first year" - an interview with Pierre Meulien
One year after taking office as the Executive Director of IMI, Pierre Meulien recounts some of the year’s highlights and explains why he believes in the model of public-private partnerships more than ever.
60th Edition – September 2016
Table of contents:
- Watch the IMI Stakeholder Forum online
- IMI2 – Call 10: indicative topics published
- IMI advanced therapies consultation – outcomes published online
- IMI at the European Week of Regions and Cities
- Lancet letter spotlights EU action on antimicrobial resistance research
- ‘Without IMI this would have never happened’ – an interview with U-BIOPRED’s Peter Sterk
- News from the projects
IMI at the European Week of Regions and Cities
The joint undertakings, including IMI, featured at the 2016 edition of the European Week of Regions and Cities with a session entitled ‘Enhance Regional Innovation and Growth: possibilities for integrated funding through regional cooperation with Joint Undertakings (JUs)’ . The ...